Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: No.
Exome sequencing in single cells from the cerebrospinal fluid in multiple sclerosis.
Glial contributions to neural function and disease.
Novartis gains FDA approval for Gilenya(TM), a novel first-line multiple sclerosis treatment shown to significantly reduce relapses and delay disability progression
Mast cells: an expanding pathophysiological role from allergy to other disorders.
The Arabic version of the Mayo-Portland Adaptability Inventory 4: a validation study.
Rehabilitation in transverse myelitis.
The role of microbiome in central nervous system disorders.
Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.
Conference Report: Multiple Sclerosis Update: Hot topics from 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS/ACTRIMS).
Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis.
Biomarkers in multiple sclerosis.
[The comparative study of efficacy and tolerability of intramuscular introduction of beta-interferon-1a in adults and adolescents with remitting multiple sclerosis.]
Cyclophosphamide for multiple sclerosis.
Elevation of Ser9 phosphorylation of GSK3β is required for HERV-W env-mediated BDNF signaling in human U251 cells.
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis.
Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo.
Capture-Recapture as a Potentially Useful Procedure for Assessing Prevalence of Multiple Sclerosis: Methodologic Exercise Using Portuguese Data.
No Association Between Conventional Brain MR Imaging and Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis.
Abstracts of ECTRIMS (Congress of the European Committee for Treatment and Research in Multiple Sclerosis) 2013. October 2-5, 2013. Copenhagen, Denmark.
Neuroprotective effects of riluzole in neurotrauma models: a review.
Cerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosis.
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Subcutaneous interferon β-1a in pediatric patients with multiple sclerosis: Regional differences in clinical features, disease management, and treatment outcomes in an international retrospective study.

Pages